{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:00:56Z","timestamp":1771264856957,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["U54AI-065357"],"award-info":[{"award-number":["U54AI-065357"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.vaccine.2013.11.016","type":"journal-article","created":{"date-parts":[[2013,11,17]],"date-time":"2013-11-17T05:15:27Z","timestamp":1384665327000},"page":"258-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain"],"prefix":"10.1016","volume":"32","author":[{"given":"Amanda E.","family":"Calvert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandice L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Delorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol D.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Roehrig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.11.016_bib0005","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ento.54.110807.090510","article-title":"Ecology and geographical expansion of Japanese encephalitis virus","volume":"54","author":"van den Hurk","year":"2009","journal-title":"Annu Rev Entomol"},{"issue":"6-7","key":"10.1016\/j.vaccine.2013.11.016_bib0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1863-2378.2008.01208.x","article-title":"The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses","volume":"56","author":"Mackenzie","year":"2009","journal-title":"Zoonoses Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.016_bib0015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","article-title":"Current use and development of vaccines for Japanese encephalitis","volume":"8","author":"Beasley","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"9602","key":"10.1016\/j.vaccine.2013.11.016_bib0020","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(07)61780-2","article-title":"Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial","volume":"370","author":"Tauber","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.016_bib0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/590116","article-title":"Randomized: double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine","volume":"198","author":"Tauber","year":"2008","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2013.11.016_bib0030","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.vaccine.2008.12.062","article-title":"Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study","volume":"27","author":"Schuller","year":"2009","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2013.11.016_bib0035","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2010.07.040","article-title":"Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine: IXIARO (IC51), in 6 months of follow-up","volume":"28","author":"Dubischar-Kastner","year":"2010","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2013.11.016_bib0040","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00705-012-1337-4","article-title":"The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system","volume":"157","author":"Clark","year":"2012","journal-title":"Arch Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.11.016_bib0045","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1128\/JVI.72.12.10286-10291.1998","article-title":"Resistance to alpha\/beta interferons correlates with the epizootic and virulence potential of Venezuelan equine encephalitis viruses and is determined by the 5\u2032 noncoding region and glycoproteins","volume":"72","author":"Spotts","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.016_bib0050","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2013.11.016_bib0055","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1099\/vir.0.81256-0","article-title":"Non-structural proteins of dengue 2 virus offer limited protection to interferon-deficient mice after dengue 2 virus challenge","volume":"87","author":"Calvert","year":"2006","journal-title":"J Gen Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2013.11.016_bib0060","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1016\/j.vaccine.2012.03.003","article-title":"A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain","volume":"30","author":"Thibodeaux","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.016_bib0065","series-title":"Semiparametric regression","author":"Ruppert","year":"2003"},{"issue":"7","key":"10.1016\/j.vaccine.2013.11.016_bib0070","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JVI.74.7.3020-3028.2000","article-title":"Chimeric dengue type 2 (vaccine strain PDK-53)\/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine","volume":"74","author":"Huang","year":"2000","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.016_bib0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.vaccine.2013.11.016_bib0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11908-010-0098-z","article-title":"New vaccines for Japanese encephalitis","volume":"12","author":"Halstead","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2013.11.016_bib0085","first-page":"77","article-title":"Selection of better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis. I. Some biological characteristics of SA14-14-2 mutant","volume":"1","author":"Yu","year":"1981","journal-title":"Chin J Microbiol Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.11.016_bib0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","article-title":"Japanese encephalitis virus live-attenuated vaccine: Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use","volume":"6","author":"Eckels","year":"1988","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2013.11.016_bib0095","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMc0808664","article-title":"Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis","volume":"360","author":"Kumar","year":"2009","journal-title":"N Engl J Med"},{"issue":"9015","key":"10.1016\/j.vaccine.2013.11.016_bib0100","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1988.39.214","article-title":"Safety of a live-attenuated Japanese encephalitis-virus vaccine (Sa14-14-2) for children","volume":"39","author":"Yu","year":"1988","journal-title":"Am J Trop Med Hygiene"},{"issue":"14","key":"10.1016\/j.vaccine.2013.11.016_bib0110","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","article-title":"Long term immunity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO(R): IC51","volume":"29","author":"Eder","year":"2011","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2013.11.016_bib0115","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1016\/j.vaccine.2011.09.114","article-title":"Flaviviruses and flavivirus vaccines","volume":"30","author":"Heinz","year":"2012","journal-title":"Vaccine"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2013.11.016_bib0120","article-title":"Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14","volume":"76","author":"Ni","year":"1995","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.016_bib0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virol.2007.04.016","article-title":"JE Nakayama\/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease","volume":"366","author":"Chambers","year":"2007","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2013.11.016_bib0135","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1016\/j.vaccine.2009.03.007","article-title":"A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2013.11.016_bib0140","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1128\/JVI.76.10.4901-4911.2002","article-title":"Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus","volume":"76","author":"Lee","year":"2002","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0042-6822(90)90519-W","article-title":"Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative: SA-14-14-2","volume":"177","author":"Nitayaphan","year":"1990","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.016_bib0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.icb.7100012","article-title":"Immunopathology of flavivirus infections","volume":"85","author":"King","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.11.016_bib0155","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/JVI.74.11.4957-4966.2000","article-title":"Modulation of dengue virus infection in human cells by alpha: beta, and gamma interferons","volume":"74","author":"Diamond","year":"2000","journal-title":"J Virol"},{"issue":"43","key":"10.1016\/j.vaccine.2013.11.016_bib0160","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1016\/j.vaccine.2009.07.078","article-title":"Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus","volume":"27","author":"Li","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.11.016_bib0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-8-39","article-title":"Japanese encephalitis Virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells","volume":"8","author":"Cao","year":"2011","journal-title":"Virol J"},{"issue":"10","key":"10.1016\/j.vaccine.2013.11.016_bib0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00705-012-1386-8","article-title":"Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions","volume":"157","author":"Sooryanarain","year":"2012","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.016_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2012.02.001","article-title":"A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129\/17D-204 peripheral challenge mouse model","volume":"94","author":"Thibodeaux","year":"2012","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0180","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/JVI.65.2.880-886.1991","article-title":"Japanese encephalitis virus neurotropism is dependent on the degree of neuronal maturity","volume":"65","author":"Ogata","year":"1991","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2013.11.016_bib0185","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/142.3.394","article-title":"Protection against Japanese encephalitis virus in mice and hamsters by treatment with carboxymethylacridanone: a potent interferon inducer","volume":"142","author":"Taylor","year":"1980","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.11.016_bib0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0168-1702(96)01343-3","article-title":"A highly attenuated strain of Japanese encephalitis virus induces a protective immune response in mice","volume":"44","author":"Lin","year":"1996","journal-title":"Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0195","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00705-012-1489-2","article-title":"Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo","volume":"158","author":"Ishag","year":"2013","journal-title":"Arch Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2013.11.016_bib0200","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1128\/JVI.02611-10","article-title":"Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis","volume":"85","author":"Larena","year":"2011","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2013.11.016_bib0205","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody","volume":"87","author":"Larena","year":"2013","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.11.016_bib0210","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S0002-9440(10)64305-2","article-title":"Beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis","volume":"162","author":"Klingel","year":"2003","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.vaccine.2013.11.016_bib0215","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1086\/423328","article-title":"Proinflammatory cytokines and chemokines in humans with Japanese encephalitis","volume":"190","author":"Winter","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1096-9071(199702)51:2<132::AID-JMV8>3.0.CO;2-8","article-title":"Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients","volume":"51","author":"Ravi","year":"1997","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2013.11.016_bib0225","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"issue":"21","key":"10.1016\/j.vaccine.2013.11.016_bib0230","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1128\/JVI.00935-08","article-title":"Toll-like receptor 3 has a protective role against West Nile virus infection","volume":"82","author":"Daffis","year":"2008","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2013.11.016_bib0235","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/jmv.21688","article-title":"Immunomodulatory cytokines determine the outcome of Japanese encephalitis virus infection in mice","volume":"82","author":"Biswas","year":"2010","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2013.11.016_bib0240","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.ijid.2011.12.010","article-title":"Cytokine and chemokine responses to Japanese encephalitis live attenuated vaccine in a human population","volume":"16","author":"Zhang","year":"2012","journal-title":"Int J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13015338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T03:37:09Z","timestamp":1596857829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13015338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0264410X13015338"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a small animal peripheral challenge model of Japanese encephalitis virus using interferon deficient AG129 mice and the SA14-14-2 vaccine virus strain","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}